These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27660080)

  • 61. High rates of surveillance imaging for treated diffuse large B-cell lymphoma: findings from a large national database.
    Abel GA; Vanderplas A; Rodriguez MA; Crosby AL; Czuczman MS; Niland JC; Gordon LI; Millenson M; Zelenetz AD; Friedberg JW; LaCasce AS
    Leuk Lymphoma; 2012 Jun; 53(6):1113-6. PubMed ID: 22098406
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Outcome analysis of high-dose chemotherapy and autologous stem cell transplantation in adolescent and young adults with relapsed or refractory Hodgkin lymphoma.
    Akhtar S; Rauf SM; Elhassan TA; Maghfoor I
    Ann Hematol; 2016 Sep; 95(9):1521-35. PubMed ID: 27376363
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients.
    Caimi PF; William BM; Silva Rondon CH; Fu P; Cooper BW; Campagnaro EL; Gerson SL; Reese-Koc J; Fox R; Creger RJ; de Lima M; Lazarus HM
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1926-31. PubMed ID: 26087475
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pre-transplant (18)F-fluorodeoxyglucose positron emission tomography-based survival model in patients with aggressive lymphoma undergoing high-dose chemotherapy and autologous SCT.
    Akhtar S; Al-Sugair AS; Abouzied M; Alkadhi Y; Dingle M; Abdelsalam M; Soudy H; Darwish A; Eltigani A; Elhassan TA; Nabil-Ahmed M; Maghfoor I
    Bone Marrow Transplant; 2013 Apr; 48(4):551-6. PubMed ID: 22964592
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [AUTOLOGOUS STEM CELL TRANSPLANTATION IN REFRACTORY OR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA - A SINGLE CENTRE EXPERIENCE].
    Milunović V; Patekar MB; Roso V; Zatezalo V; Stipinović BA; Jakobac KM; Šimec NG; Radić-Krišto D; Planinc-Peraica A; Kolonić SO
    Lijec Vjesn; 2015; 137(9-10):276-82. PubMed ID: 26749949
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Autologous stem cell transplantation in elderly patients (> or =60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation registry.
    Jantunen E; Canals C; Rambaldi A; Ossenkoppele G; Allione B; Blaise D; Conde E; Tilly H; Cook G; Clark F; Gallamini A; Haynes A; Mounier N; Dreger P; Pfreundschuh M; Sureda A;
    Haematologica; 2008 Dec; 93(12):1837-42. PubMed ID: 18838474
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation-study on behalf of CMWP of the EBMT.
    Drozd-Sokołowska J; Gras L; Zinger N; Snowden JA; Arat M; Basak G; Pouli A; Crawley C; Wilson KMO; Tilly H; Byrne J; Bulabois CE; Passweg J; Ozkurt ZN; Schroyens W; Lioure B; Colorado Araujo M; Poiré X; Van Gorkom G; Gurman G; de Wreede LC; Hayden PJ; Beksac M; Schönland SO; Yakoub-Agha I
    Bone Marrow Transplant; 2022 Apr; 57(4):633-640. PubMed ID: 35169284
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Symptom-oriented clinical detection versus routine imaging as a monitoring policy of relapse in patients with diffuse large B-cell lymphoma.
    Hong J; Kim JH; Lee KH; Ahn HK; Park S; Sym SJ; Park J; Cho EK; Shin DB; Lee JH
    Leuk Lymphoma; 2014 Oct; 55(10):2312-8. PubMed ID: 24428199
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Is It a Valid Treatment Option?
    Mondello P; Steiner N; Willenbacher W; Ferrero S; Ghione P; Marabese A; Pitini V; Cuzzocrea S; Mian M
    Oncologist; 2016 Sep; 21(9):1107-12. PubMed ID: 27382029
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A retrospective comparison of autologous and unrelated donor hematopoietic cell transplantation in myelodysplastic syndrome and secondary acute myeloid leukemia: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Al-Ali HK; Brand R; van Biezen A; Finke J; Boogaerts M; Fauser AA; Egeler M; Cahn JY; Arnold R; Biersack H; Niederwieser D; de Witte T
    Leukemia; 2007 Sep; 21(9):1945-51. PubMed ID: 17611571
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Limited utility of surveillance imaging for detecting disease relapse in patients with non-Hodgkin lymphoma in first complete remission.
    Truong Q; Shah N; Knestrick M; Curley B; Hu Y; Craig M; Hamadani M
    Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):50-5. PubMed ID: 24119465
    [TBL] [Abstract][Full Text] [Related]  

  • 72. High-dose chemotherapy with autologous stem cell transplantation for elderly patients with relapsed/refractory diffuse large B cell lymphoma: a nationwide retrospective study.
    Chihara D; Izutsu K; Kondo E; Sakai R; Mizuta S; Yokoyama K; Kaneko H; Kato K; Hasegawa Y; Chou T; Sugahara H; Henzan H; Sakamaki H; Suzuki R; Suzumiya J
    Biol Blood Marrow Transplant; 2014 May; 20(5):684-9. PubMed ID: 24492141
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up.
    Björkstrand B; Iacobelli S; Hegenbart U; Gruber A; Greinix H; Volin L; Narni F; Musto P; Beksac M; Bosi A; Milone G; Corradini P; Goldschmidt H; de Witte T; Morris C; Niederwieser D; Gahrton G
    J Clin Oncol; 2011 Aug; 29(22):3016-22. PubMed ID: 21730266
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Autologous transplant remains the preferred therapy for relapsed APL in CR2.
    Ganzel C; Mathews V; Alimoghaddam K; Ghavamzadeh A; Kuk D; Devlin S; Wang H; Zhang MJ; Weisdorf D; Douer D; Rowe JM; Polge E; Esteve J; Nagler A; Mohty M; Tallman MS
    Bone Marrow Transplant; 2016 Sep; 51(9):1180-3. PubMed ID: 27088379
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical Outcome of Autologous Hematopoietic Cell Transplantation in Adult Patients with Acute Myeloid Leukemia: Who May Benefit from Autologous Hematopoietic Cell Transplantation?
    Yoon JH; Kim HJ; Park SS; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):588-597. PubMed ID: 28089879
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long-term outcome of allogeneic or autologous haemopoietic cell transplantation for acute lymphoblastic leukaemia in second remission in children. GETMON experience 1983-1998.
    Badell I; Muñoz A; Ortega JJ; Martínez A; Madero L; Bureo E; Verdeguer A; Fernandez-Delgado R; Cubells J; Soledad-Maldonado M; Olivé T; Sastre A; Baro J; Díaz MA;
    Bone Marrow Transplant; 2005 May; 35(9):895-901. PubMed ID: 15778727
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Limited clinical benefit for surveillance PET-CT scanning in patients with histologically transformed lymphoma in complete metabolic remission following primary therapy.
    Cheah CY; Dickinson M; Hofman MS; George A; Ritchie DS; Prince HM; Westerman D; Harrison SJ; Burbury K; Wolf M; Januszewicz H; Herbert KE; Carney DA; Tam C; Seymour JF
    Ann Hematol; 2014 Jul; 93(7):1193-200. PubMed ID: 24595733
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Autologous hematopoietic stem cell transplantation as late high-dose consolidation in adult patients with T-cell lymphoblastic leukemias: Results of a Russian multicenter study].
    Parovichnikova EN; Kuzmina LA; Mendeleeva LP; Klyasova GA; Troitskaya VV; Sokolov AN; Akhmerzaeva ZK; Kravchenko SK; Gribanova EO; Zvonkov EE; Bondarenko SN; Baranova OY; Ryltsova TV; Gavrilova LV; Zinina EE; Pristupa AS; Kaporskaya TS; Minaeva NV; Samoilova OS; Konstantinova TS; Lapin VA; Kaplanov KD; Kryuchkova IV; Nizamutdinova AS; Klimovich AV; Borisenkova EA; Moskov VI; Gaponova TV; Obukhova TV; Galtseva IV; Rusinov MA; Kulikov SM; Savchenko VG
    Ter Arkh; 2015; 87(7):15-25. PubMed ID: 26390721
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The non-relapse mortality rate for patients with diffuse large B-cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controls.
    Hill BT; Rybicki L; Bolwell BJ; Smith S; Dean R; Kalaycio M; Pohlman B; Tench S; Sobecks R; Andresen S; Copelan E; Sweetenham J
    Br J Haematol; 2011 Mar; 152(5):561-9. PubMed ID: 21223255
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission.
    Vose JM; Rizzo DJ; Tao-Wu J; Armitage JO; Bashey A; Burns LJ; Christiansen NP; Freytes CO; Gale RP; Gibson J; Giralt SA; Herzig RH; Lemaistre CF; McCarthy PL; Nimer SD; Petersen FB; Schenkein DP; Wiernik PH; Wiley JM; Loberiza FR; Lazarus HM; van Biesen K; Horowitz MM
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):116-27. PubMed ID: 14750077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.